PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. We are using the highest quality science to make the therapies our pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, we are applying the cutting edge of science to bring breakthroughs for the animals we love and care for.

PetMedix is taking the experience of its founding team, and decades of human clinical research, to build platforms that generate fully species-specific, naturally-generated therapeutic antibodies. These platforms have been designed to generate a repertoire of antibodies as diverse as the companion animal immune systems on which they are based. These platforms can then be used to develop a broad pipeline of our own veterinary medicines to target under-served clinical areas that represent excellent market opportunities.